Introduction Mediators of immunity and inflammation are playing a crucial role in COVID-19
pathogenesis and complications as demonstrated by several genetic and clinical studies …

Coronaviruses are ubiquitous in nature and infects diverse species with frequent cross-
species transmission. There have been multiple events of animal to human transmission …

Background and objective The most important presentation of COVID-19 is hyper
inflammatory condition and cytokine storm that occurs due to excessive increase of the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) elicits an interferon (IFN)
deficiency state, which aggravates the type I interferon deficiency and slow IFN responses …

The rapid advancement of the COVID-19 pandemic has prompted an accelerated pursuit to
identify effective therapeutics. Stages of the disease course have been defined by viral …

For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing
drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

Azithromycin has been shown to have a clinical efficacy against severe acute respiratory
syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental …

With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain …

We have previously published several papers illustrating numerous immunomodulatory and
anti-inflammatory potential benefits when we repurposed safe, generic non-steroidal anti …